TY - JOUR T1 - No effect of desmopressin administration before kidney biopsy on the risk of major post-biopsy bleeding JO - NefrologĂ­a (English Edition) T2 - AU - Cheong,Minseon AU - Lee,Tae Yeon AU - Lee,Jongmin AU - Kim,Soon Bae SN - 20132514 M3 - 10.1016/j.nefroe.2020.12.008 DO - 10.1016/j.nefroe.2020.12.008 UR - https://www.revistanefrologia.com/en-no-effect-desmopressin-administration-before-articulo-S2013251422000347 AB - Background/AimsThe most important complication of kidney biopsy is bleeding, and it is unclear whether desmopressin is effective in preventing it. Thus, the study was conducted to compare post-biopsy bleeding with or without desmopressin prescription prior to percutaneous kidney biopsy. MethodsIn this single-centered, retrospective, and observational study, 3,018 adult patients who underwent kidney biopsy between January 1, 2003 and March 31, 2019 at our institute were recruited. Of these, 776 patients received desmopressin. To compare the differences in major bleeding events between patients administered and not administered with desmopressin, propensity score matching was performed. ResultsBefore propensity score (PS) matching, it was observed that patients in the desmopressin group were significantly older (p<0.001) and had a higher blood pressure (p<0.001), higher serum creatinine (p<0.001), lower hemoglobin levels (p<0.001), and lower platelet counts (p=0.001) than those in the no-desmopressin group. Furthermore, the incidence of renal artery embolization was not significantly different between the two groups (p=0.077); however, blood transfusions occurred significantly more frequently in the desmopressin group (p<0.001). A comparison of the two groups after PS matching did not reveal any differences in the incidence of renal artery embolization (p=0.341), blood transfusion (p=0.579), and total major bleeding events (p=0.442). Furthermore, there was no difference in the incidence of perinephric hematoma on computed tomography or ultrasound (p=0.120). ConclusionsWe do not recommend desmopressin administration before kidney biopsy. ER -